| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0041 | 1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |